+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 76Years
All Genders
ID06800391

Study of Oral Capecitabine and Cyclophosphamide Before Surgery in Adults With Large Pseudomyxoma Peritonei PCI Over 28

Led by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Updated on 2025-01-30

31

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying a treatment approach for patients with huge Pseudomyxoma peritonei PMP, a condition where mucinous tumors accumulate in the abdomen causing serious health issues. The study focuses on patients with a high peritoneal cancer index PCI >28, aiming to evaluate the safety and effectiveness of a new pre-surgery chemotherapy regimen. This phase II trial investigates whether giving low-dose oral capecitabine and cyclophosphamide before surgery can improve the chance of complete tumor removal. Participants will receive continuous low-dose capecitabine 1250 mgm2 per day and cyclophosphamide 50 mg per day for six months, given daily in 28-day cycles. After chemotherapy, patients who can undergo surgery will have cytoreductive surgery CRS combined with hyperthermic intraperitoneal chemotherapy HIPEC, the standard treatment for PMP. The study also includes staging laparoscopy to confirm diagnosis and measure tumor burden before treatment begins. Throughout the study, patients will be monitored with scans and lab tests to evaluate tumor response and safety. Researchers will measure the proportion of patients achieving complete tumor removal after chemotherapy and surgery, along with tumor size changes, complications, quality of life, and survival over time. The total study duration includes six months of treatment and follow-up assessments up to several years to understand long-term outcomes and safety.

CONDITIONS

Brief Title

Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients

Research Team

A

Alessandra Raimondi, MD

S

Shigeki Kusamura, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here